NIST, NCI, SAIC Partner on New Method for Detecting HER2 Breast Cancer (1 of 2) (IMAGE)

National Institute of Standards and Technology (NIST)

NIST, NCI, SAIC Partner on New Method for Detecting HER2 Breast Cancer (1 of 2)

Caption

Immunohistochemical detection of HER2 cancer biomarker with IgY antibody and quantum dots is demonstrated in these samples of breast cancer cells from a patient with normal HER2 expression (top) and one with over production (bottom). Cell nuclei are stained blue, quantum dots responding to the HER2 protein light up in bright red at the cell membranes. Treatment with trastuzumab could only be effective for the latter patient.

Credit

NIST

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.